These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: evidence for accommodation. Hanto DW; Fecteau AH; Alonso MH; Valente JF; Whiting JF Liver Transpl; 2003 Jan; 9(1):22-30. PubMed ID: 12514769 [TBL] [Abstract][Full Text] [Related]
10. ABO-incompatible liver transplantation in acute liver failure: a single Portuguese center study. Mendes M; Ferreira AC; Ferreira A; Remédio F; Aires I; Cordeiro A; Mascarenhas A; Martins A; Pereira P; Gloria H; Perdigoto R; Veloso J; Ferreira P; Oliveira J; Silva M; Barroso E; Nolasco F Transplant Proc; 2013 Apr; 45(3):1110-5. PubMed ID: 23622639 [TBL] [Abstract][Full Text] [Related]
11. Six consecutive cases of successful adult ABO-incompatible living donor liver transplantation: a proposal for grading the severity of antibody-mediated rejection. Morioka D; Togo S; Kumamoto T; Takeda K; Matsuo K; Inayama Y; Yamanaka S; Tanaka K; Endo I; Maegawa J; Shimada H Transplantation; 2008 Jan; 85(2):171-8. PubMed ID: 18212620 [TBL] [Abstract][Full Text] [Related]
12. First two ABO-incompatible living renal transplantations using splenectomy, rituximab, plasmapheresis and IVIG as a preconditioning regimen: a single center experience in the Balkans. Ivanovski N; Popov Z; Masin-Spasovska J; Dimcevska AH; Kolevski P Xenotransplantation; 2006 Mar; 13(2):123-5. PubMed ID: 16623805 [TBL] [Abstract][Full Text] [Related]
13. The use of extracorporeal photopheresis for allograft rejection in liver transplant recipients. Urbani L; Mazzoni A; Catalano G; De Simone P; Vanacore R; Pardi C; Bortoli M; Biancofiore G; Campani D; Perrone V; Mosca F; Scatena F; Filipponi F Transplant Proc; 2004 Dec; 36(10):3068-70. PubMed ID: 15686696 [TBL] [Abstract][Full Text] [Related]
16. A case of accelerated acute rejection after ABO-compatible living unrelated kidney transplantation. Matsuo N; Yamamoto H; Kobayashi A; Yamamoto I; Mitome J; Maruyama Y; Hayakawa H; Miyazaki Y; Utsunomiya Y; Hosoya T; Yamaguchi Y Clin Transplant; 2009 Aug; 23 Suppl 20():23-6. PubMed ID: 19594591 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens. Tanabe K; Ishida H; Shimizu T; Omoto K; Shirakawa H; Tokumoto T Contrib Nephrol; 2009; 162():61-74. PubMed ID: 19001814 [TBL] [Abstract][Full Text] [Related]
18. ABO-incompatible adult liver transplantation when the anti-ABO antibody titer is high. Shimoda M; Marubashi S; Dono K; Miyamoto A; Takeda Y; Umeshita K; Nagano H; Hoshida Y; Monden M Hepatogastroenterology; 2009; 56(93):1174-7. PubMed ID: 19760964 [TBL] [Abstract][Full Text] [Related]
19. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation. Ikegami T; Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Harada N; Iguchi T; Hashimoto N; Maehara Y Transplantation; 2009 Aug; 88(3):303-7. PubMed ID: 19667930 [TBL] [Abstract][Full Text] [Related]
20. Long-term experience of plasmapheresis in antibody-mediated rejection in renal transplantation. Brown CM; Abraham KA; O'Kelly P; Conlon PJ; Walshe JJ Transplant Proc; 2009 Nov; 41(9):3690-2. PubMed ID: 19917368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]